EUVIMEDEUVIMED entdecken
Crossref

Exosome-mediated transfer of NOD2 from platelets to monocytes: a novel therapeutic target for atherosclerosis

Guanxing Pan, Zhiyong Qi, Xiaowen Wu, Lin Chang, Wei Zhang, Jianjun Zhang, Haoxuan Zhong, Yiwei Liu, Cuihong Lin, Si Zhang, She Chen, Zhongren Ding

Biochemical Pharmacology · 2026-09 · 251 · 118183

DOI: 10.1016/j.bcp.2026.118183 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical Pharmacology, 2026-09. Verfasst von Guanxing Pan und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, the First Affiliated Hospital, Fujian Medical University, Fuzhou 350005, China; Clinical Pharmacology Research Center, Nation…. Hauptthemen laut MEDLINE: Nod2 Signaling Adaptor Protein, Atherosclerosis, Exosomes, Monocytes. Die Arbeit nennt 70 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atherosclerosis, the pathological basis of cardiovascular diseases including coronary artery disease and ischemic stroke, is increasingly recognized as a chronic inflammatory disease. The contribution of nucleotide-binding oligomerization domain containing 2 (NOD2), a key pattern recognition receptor in immunity, to atherosclerosis remains poorly defined. This study investigated the role of NOD2 in platelet-mediated monocyte activation and evaluated the therapeutic potential of pharmacological NOD2 inhibition. NOD2 protein wasdecreased in platelets from atherosclerotic patients and mice, accompanied by elevated NOD2 expression in peripheral blood mononuclear cells. These alterations were not attributable to transcriptional regulation. Plasma exosomes from atherosclerotic patients contained increased NOD2 protein. Accordingly, platelet activation caused a reduction in NOD2 protein within platelets and the release of NOD2-enriched exosomes that increased NOD2 expression in THP-1 monocytes. NOD2 overexpression in THP-1 cells enhanced cell migration and proinflammatory response without affecting cell adhesion and differentiation, whereas treatment with the NOD2 receptor antagonist GSK669 attenuated both processes. Mechanistically, NOD2 upregulated LOX-1 and activated the RIP2/JNK/p38 axis during THP-1 differentiation. In hyperlipidemic ApoE-/- mice, platelet-derived exosomes carrying NOD2 exacerbated atherosclerosis, while intravenous administration of GSK669 attenuated atherosclerosis and showed efficacy comparable to aspirin in this mouse model. In conclusion, we uncover a previously unrecognized mechanism whereby platelet-to-monocyte transfer of NOD2 via exosomes drives monocyte inflammation and migration, exacerbating atherosclerosis. The anti-atherosclerotic effects of GSK669, a NOD2 receptor antagonist with previously reported antithrombotic efficacy comparable to aspirin and a favorable bleeding profile in mice, highlight NOD2 antagonism as a promising alternative therapeutic strategy against atherosclerosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nod2 Signaling Adaptor ProteinAtherosclerosisExosomesMonocytesBlood PlateletsAnimalsHumansMiceMice, Inbred C57BLTHP-1 CellsMaleMice, Knockout, ApoE

Stichwörter der Autor:innen

AtherosclerosisExosomeGSK669NOD2Platelet

Substanzen

Nod2 Signaling Adaptor ProteinNod2 protein, mouseNOD2 protein, human

Autor:innen und Institutionen

  • Department of Pharmacy, the First Affiliated Hospital, Fujian Medical University, Fuzhou 350005, China; Clinical Pharmacology Research Center, National Regional Medical Center, Binhai Campus of the First Affiliated Hosp…
  • Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
  • School of Pharmacy, Tianjin Medical University, Tianjin 300070, China.
  • Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China.
  • Department of Clinical Laboratory, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai 200135, China.
  • School of Pharmacy, Tianjin Medical University, Tianjin 300070, China; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China; Department of Geriatri…

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Pan, G., Qi, Z., Wu, X., Chang, L., Zhang, W., Zhang, J., Zhong, H., Liu, Y., Lin, C., Zhang, S., Chen, S., & Ding, Z. (2026). Exosome-mediated transfer of NOD2 from platelets to monocytes: a novel therapeutic target for atherosclerosis. Biochemical Pharmacology, 251, 118183. https://doi.org/10.1016/j.bcp.2026.118183

Vancouver

Pan G, Qi Z, Wu X, Chang L, Zhang W, Zhang J, et al. Exosome-mediated transfer of NOD2 from platelets to monocytes: a novel therapeutic target for atherosclerosis. Biochemical Pharmacology. 2026;251:118183. doi:10.1016/j.bcp.2026.118183

BibTeX
@article{Pan2026,
  author = {Pan, Guanxing and Qi, Zhiyong and Wu, Xiaowen and Chang, Lin and Zhang, Wei and Zhang, Jianjun and Zhong, Haoxuan and Liu, Yiwei and Lin, Cuihong and Zhang, Si and Chen, She and Ding, Zhongren},
  title = {Exosome-mediated transfer of NOD2 from platelets to monocytes: a novel therapeutic target for atherosclerosis},
  journal = {Biochemical Pharmacology},
  year = {2026},
  volume = {251},
  pages = {118183},
  doi = {10.1016/j.bcp.2026.118183}
}
Kostenlos starten →